Market revenue in 2021 | USD 511.2 million |
Market revenue in 2028 | USD 862.3 million |
Growth rate | 7.8% (CAGR from 2021 to 2028) |
Largest segment | Reagents & kits |
Fastest growing segment | Reagents & Kits |
Historical data | 2016 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents & Kits, Analyzers/Instruments, Software & Services |
Key market players worldwide | BioMerieux SA, Abbott Laboratories, Roche Holding AG, Siemens Healthineers AG ADR, Becton Dickinson & Co, Bio-Rad Laboratories Inc Class A, Beckman Coulter |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay analyzers market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 66.29% in 2021. Horizon Databook has segmented the Spain immunoassay analyzers market based on reagents & kits, analyzers/instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
According to the Secretary of State for Health, Spain has increased its healthcare expenditure for 2021 by over USD 3.4 billion (EUR 3 billion) in comparison with the increase in 2020 by USD 373.1 million (EUR 326.85 million).
This initiative is expected to increase the spending for public health programs, especially targeting hepatitis, tuberculosis, HIV, and AIDS. Increased funding for the National Health System Quality Plan for strategies related to cancer, rare diseases, and chronic diseases is likely to improve the health system and strengthen the National Health System.
Factors such as obesity, diabetes, smoking, lack of exercise, high blood pressure, and high cholesterol have resulted in increased incidence of cardiovascular diseases in the country. Furthermore, according to International Diabetes Federation, about 3,584,500 people were estimated to be affected with diabetes in 2017 and the prevalence was estimated to be 10.4%.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain immunoassay analyzers market , including forecasts for subscribers. This country databook contains high-level insights into Spain immunoassay analyzers market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account